CE Mark for predictive test for diabetic kidney disease

Proteomics International is proud to announce it has secured CE Mark registration for PromarkerD (MS) as an IVD medical device (in vitro diagnostic).

PromarkerD is the world-leading test for predicting the onset of diabetic kidney disease. PromarkerD was registered for use in the Europe Union (EU) as part of the company’s program of future asset registration.

Media Release


  • This field is for validation purposes and should be left unchanged.